Systematic Characterization of Prognostic Values of Peroxiredoxin Family in Gastric Cancer

Table 4

Association between PRDX expression and OS in GC patients with different differentiation degree.

PRDXs	Differentiation degree	Cases	Low	High	HR (95% CI)	value
PRDX1	Poor	165	82	83	1.40 (0.94–2.08)	0.098
	Moderate	67	34	33	0.85 (0.44–1.63)	0.629
	Good	32	16	16	1.07 (0.46–2.54)	0.870
PRDX2	Poor	165	82	83	0.87 (0.58–1.30)	0.494
	Moderate	67	34	33	0.32 (0.16–0.63)	<0.001
	Good	32	16	16	0.61 (0.26–1.46)	0.268
PRDX3	Poor	165	82	83	1.06 (0.71–1.57)	0.792
	Moderate	67	34	33	0.57 (0.30–1.10)	0.091
	Good	32	16	16	0.66 (0.28–1.57)	0.344
PRDX4	Poor	165	82	83	1.25 (0.84–1.86)	0.271
	Moderate	67	34	33	0.59 (0.30–1.14)	0.113
	Good	32	16	16	0.48 (0.20–1.17)	0.099
PRDX5	Poor	121	60	61	1.15 (0.71–1.86)	0.573
	Moderate	67	34	33	0.82 (0.43–1.57)	0.544
	Good	5	2	3	—	0.221
PRDX6	Poor	165	82	83	0.88 (0.59–1.30)	0.512
	Moderate	67	34	33	1.10 (0.57–2.11)	0.775
	Good	32	16	16	1.33 (0.56–3.13)	0.518